Not exact matches
There has been concern raised about a resurgence of vitamin D deficiency and rickets among infants and children, with
reports emerging in the United States from Alaska, 1,2 Iowa, 3 Nevada, 4 California, 5 North Carolina, 6 Texas, 7 and mother - infant pairs in Boston, 8 among others.9 The prevalence of vitamin D deficiency in young children also appears to be high in other countries, including England, 10 Greece, 11 and Canada.12, 13 One
study from China found a 65.3 % prevalence of vitamin D deficiency among 12 - to 24 - month - olds, but few
cases (3.7 %) of radiographic or
clinical rickets were noted.14 Previous
studies suggest risk factors to be dark skin pigmentation1,3 - 12 and breastfeeding without supplementation.1 - 7, 9,12,13 To date,
reports have focused primarily on young infants compared with toddlers.
Furthermore, the
report accuses the British Homeopathic Association (BHA), which had submitted evidence to the panel, of cherry - picking, and even, in one
case actively misrepresenting, research into the treatment (a famous
study that concluded its findings were «compatible with the notion that the
clinical effects of homeopathy are placebo effects» was cited by the BHA as evidence of the treatment's efficacy.)
In three new
studies in the current issue of the International Journal of Infectious Disease, researchers
reported on
clinical outcomes in the Kingdom of Saudi Arabia (KSA), how long patients will shed virus during their infections, and how the Sultanate of Oman is dealing with
cases that have appeared there.
The British Journal of
Clinical Pharmacology analysis included 49
case reports and two observational
studies with 15
cases of adverse drug reactions.
Her 1990
case - control
study,
reported in the Journal of
Clinical Epidemiology, found no association between aluminum - containing products and Alzheimer's disease.
He said the new
study demonstrates the power of liquid biopsies of resistant cancers to identify the biological causes and — in the present
case —
report those mechanisms simultaneously with the publication of the
clinical trial results for a new drug.
In a rare move, the companies that make the multiple sclerosis drug daclizumab (brand name Zinbryta) have voluntarily pulled the medication from the market and stopped all
clinical studies after
reports of eight
cases of serious brain inflammation among patients in Europe.
Of the 34 published
reports with sufficient
clinical information on at least 1 component of CZS, 11 were single
case descriptions,13 - 23 21
case series,10,24 - 43 1 cohort
study, 44 and 1
case - control
study.7 Two
reports contain information on pregnancies in French Polynesia24, 29 and 29 in Brazil; and there were 2 such
reports in the United States13, 15 and 1 in Spain, 20 with exposure outside the countries of birth.
This species has a history of use in traditional Chinese medicine and although there have been anecdotal
reports of benefits, there have been no
clinical controlled
studies to test the efficacy of this herb (herb, here referring to a general term that may be either a plant, root, mold, and in this
case, a parasite.)
We support veterinary practitioners worldwide through a network of experts that provide advice on
cases, continuing education opportunities, a high - quality scientific journal, educational resources and assistance in the design and
reporting of
clinical studies.
In a recent retrospective
study of 70 dogs with fatal pancreatitis the following
clinical signs were
reported: anorexia in 91 % of the
cases, vomiting in 90 %, weakness in 79 %, abdominal pain in 58 %, dehydration in 46 %, and diarrhea in 33 %.
-- Updated
case reports and source documents for
clinical trials, arranged
study interviews, and recruitment — Updated medical records, maintained information on protocol and
case reports for each trial, developed flow sheets and identified subject eligibility — Performed QA / QC procedures, worksheets and
study materials, collected data and ordered supplies — Prepared consent amendments and processed specimens — Prepared sponsor files for FDA compliance and GCP guidelines
Assisted other therapeutic teams with processing
case report forms (CRF) from various
clinical studies and spontaneous consumer
reports
Group Pension and Administrators (Richardson, TX) 2007 — 2010 Medical Data /
Reporting Analyst • Implemented tactics to decreased time for generating specialized
reports by 50 % on
clinical financial research • Researched
case studies needing Benefit Modelers and benchmark resulting in efficient aid in negotiations and cost analysis • Analyzed / interpreted data, problem solved, and communicated solutions for a variety of issues across multiple departments • Provided multiple solutions for cost drivers using medical related software showing cause and effect relationships
Many of the scales demonstrated weak psychometrics in at least one of the following ways: (a) lack of psychometric data [i.e., reliability and / or validity; e.g., HFQ, MASC, PBS, Social Adjustment Scale - Self -
Report (SAS - SR) and all perceived self - esteem and self - concept scales], (b) items that fall on more than one subscale (e.g., CBCL - 1991 version), (c) low alpha coefficients (e.g., below.60) for some subscales, which calls into question the utility of using these subscales in research and clinical work (e.g., HFQ, MMPI - A, CBCL - 1991 version, BASC, PSPCSAYC), (d) high correlations between subscales (e.g., PANAS - C), (e) lack of clarity regarding clinically - relevant cut - off scores, yielding high false positive and false negative rates (e.g., CES - D, CDI) and an inability to distinguish between minor (i.e., subclinical) and major (i.e., clinical) «cases» of a disorder (e.g., depression; CDI, BDI), (f) lack of correspondence between items and DSM criteria (e.g., CBCL - 1991 version, CDI, BDI, CES - D, (g) a factor structure that lacks clarity across studies (e.g., PSPCSAYC, CASI; although the factor structure is often difficult to assess in studies of pediatric populations, given the small sample sizes), (h) low inter-rater reliability for interview and observational methods (e.g., CGAS), (i) low correlations between respondents such as child, parent, teacher [e.g., BASC, PSPCSAYC, CSI, FSSC - R, SCARED, Connors Ratings Scales - Revised (CRS - R)-RSB-, (j) the inclusion of somatic or physical symptom items on mental health subscales (e.g., CBCL), which is a problem when conducting studies of children with pediatric physical conditions because physical symptoms may be a feature of the condition rather than an indicator of a mental health problem, (k) high correlations with measures of social desirability, which is particularly problematic for the self - related rating scales and for child - report scales more generally, and (l) content validity problems (e.g., the RCMAS is a measure of anxiety, but contains items that tap mood, attention, peer interactions, and impulsi
Report (SAS - SR) and all perceived self - esteem and self - concept scales], (b) items that fall on more than one subscale (e.g., CBCL - 1991 version), (c) low alpha coefficients (e.g., below.60) for some subscales, which calls into question the utility of using these subscales in research and
clinical work (e.g., HFQ, MMPI - A, CBCL - 1991 version, BASC, PSPCSAYC), (d) high correlations between subscales (e.g., PANAS - C), (e) lack of clarity regarding clinically - relevant cut - off scores, yielding high false positive and false negative rates (e.g., CES - D, CDI) and an inability to distinguish between minor (i.e., subclinical) and major (i.e.,
clinical) «
cases» of a disorder (e.g., depression; CDI, BDI), (f) lack of correspondence between items and DSM criteria (e.g., CBCL - 1991 version, CDI, BDI, CES - D, (g) a factor structure that lacks clarity across
studies (e.g., PSPCSAYC, CASI; although the factor structure is often difficult to assess in
studies of pediatric populations, given the small sample sizes), (h) low inter-rater reliability for interview and observational methods (e.g., CGAS), (i) low correlations between respondents such as child, parent, teacher [e.g., BASC, PSPCSAYC, CSI, FSSC - R, SCARED, Connors Ratings Scales - Revised (CRS - R)-RSB-, (j) the inclusion of somatic or physical symptom items on mental health subscales (e.g., CBCL), which is a problem when conducting
studies of children with pediatric physical conditions because physical symptoms may be a feature of the condition rather than an indicator of a mental health problem, (k) high correlations with measures of social desirability, which is particularly problematic for the self - related rating scales and for child -
report scales more generally, and (l) content validity problems (e.g., the RCMAS is a measure of anxiety, but contains items that tap mood, attention, peer interactions, and impulsi
report scales more generally, and (l) content validity problems (e.g., the RCMAS is a measure of anxiety, but contains items that tap mood, attention, peer interactions, and impulsivity).
Includes
case studies and
clinical reports that describe innovative evaluation and intervention techniques with persons with developmental and physical disabilities